Epstein Becker Green provided comprehensive legal and regulatory analysis for the nationwide expansion of a telemedicine company specializing in women’s reproductive health.
Each state-specific analysis covered numerous areas, including requirements related to corporate practice of medicine, acceptable telemedicine modalities, licensure, establishing a practitioner-patient relationship, informed consent to telemedicine, remote prescribing, scope of practice, standard of care, medical records, COVID-19 considerations, identification of patient and physician, follow-up care, disclosure of risks of telemedicine, age of consent / minor’s right to consent, and fee splitting.
Results may vary depending on your particular facts and legal circumstances.
People
- Member of the Firm
- Member of the Firm
- Associate
- Associate
- Associate